Deutsche Bank Ag\ Adamis Pharmaceuticals Corp Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.7 - $1.46 $18,865 - $39,348	-26,951 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.26 - $2.23 $33,958 - $60,100	26,951 New	26,951 $35,000
Q4 2018 Feb 14, 2019	SELL	$2.1 - $3.21 $52,468 - $80,201	-24,985 Closed	0 $0
Q3 2018 Dec 21, 2021	SELL	$2.25 - $4.8 $11 - $24	-5 Reduced 0.02%	24,985 $87,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $53,680 - $114,518	23,858 Added 2107.6%	24,990 $87,000
Q2 2018 Apr 21, 2020	SELL	$3.2 - $4.7 $16 - $23	-5 Reduced 0.44%	1,132 $4,000
Q2 2018 Aug 14, 2018	SELL	$3.2 - $4.7 $18,976 - $27,871	-5,930 Reduced 83.91%	1,137 $3,000
Q1 2018 Oct 18, 2019	SELL	$2.55 - $4.85 $12 - $24	-5 Reduced 0.07%	7,067 $24,000
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $17,429 - $33,149	6,835 Added 2883.97%	7,072 $24,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $266 - $429	76 Added 47.2%	237 $1,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $724 - $909	161	161 $0

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.